Lexaria Bioscience Corp Stock Market Value
| LEXXW Stock | USD 0.75 0.04 5.63% |
| Symbol | Lexaria |
Lexaria Bioscience Corp Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexaria Bioscience. If investors know Lexaria will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexaria Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.039 | Quarterly Revenue Growth 0.081 | Return On Assets (0.38) | Return On Equity (0.71) |
The market value of Lexaria Bioscience Corp is measured differently than its book value, which is the value of Lexaria that is recorded on the company's balance sheet. Investors also form their own opinion of Lexaria Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Lexaria Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexaria Bioscience's market value can be influenced by many factors that don't directly affect Lexaria Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexaria Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lexaria Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexaria Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lexaria Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lexaria Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lexaria Bioscience.
| 11/19/2023 |
| 12/13/2024 |
If you would invest 0.00 in Lexaria Bioscience on November 19, 2023 and sell it all today you would earn a total of 0.00 from holding Lexaria Bioscience Corp or generate 0.0% return on investment in Lexaria Bioscience over 390 days. Lexaria Bioscience is related to or competes with Lexaria Bioscience, GeoVax Labs, Reviva Pharmaceuticals, and Immatics Biotechnologies. Lexaria Bioscience Corp. operates in the drug delivery platform business More
Lexaria Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lexaria Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lexaria Bioscience Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.65 | |||
| Information Ratio | 8.0E-4 | |||
| Maximum Drawdown | 69.73 | |||
| Value At Risk | (14.61) | |||
| Potential Upside | 20.29 |
Lexaria Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lexaria Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lexaria Bioscience's standard deviation. In reality, there are many statistical measures that can use Lexaria Bioscience historical prices to predict the future Lexaria Bioscience's volatility.| Risk Adjusted Performance | 0.0175 | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (1.39) | |||
| Sortino Ratio | 8.0E-4 | |||
| Treynor Ratio | 0.0293 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lexaria Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lexaria Bioscience Corp Backtested Returns
At this stage we consider Lexaria Stock to be out of control. Lexaria Bioscience Corp has Sharpe Ratio of 0.0041, which conveys that the firm had a 0.0041% return per unit of risk over the last 3 months. We have found thirty technical indicators for Lexaria Bioscience, which you can use to evaluate the volatility of the firm. Please verify Lexaria Bioscience's Mean Deviation of 7.44, risk adjusted performance of 0.0175, and Downside Deviation of 10.65 to check out if the risk estimate we provide is consistent with the expected return of 0.0439%. The company secures a Beta (Market Risk) of 3.78, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lexaria Bioscience will likely underperform. Lexaria Bioscience Corp right now secures a risk of 10.69%. Please verify Lexaria Bioscience Corp potential upside, accumulation distribution, price action indicator, as well as the relationship between the expected short fall and day median price , to decide if Lexaria Bioscience Corp will be following its current price movements.
Auto-correlation | -0.33 |
Poor reverse predictability
Lexaria Bioscience Corp has poor reverse predictability. Overlapping area represents the amount of predictability between Lexaria Bioscience time series from 19th of November 2023 to 1st of June 2024 and 1st of June 2024 to 13th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lexaria Bioscience Corp price movement. The serial correlation of -0.33 indicates that nearly 33.0% of current Lexaria Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.33 | |
| Spearman Rank Test | -0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Lexaria Bioscience Corp lagged returns against current returns
Autocorrelation, which is Lexaria Bioscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lexaria Bioscience's stock expected returns. We can calculate the autocorrelation of Lexaria Bioscience returns to help us make a trade decision. For example, suppose you find that Lexaria Bioscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lexaria Bioscience regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lexaria Bioscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lexaria Bioscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lexaria Bioscience stock over time.
Current vs Lagged Prices |
| Timeline |
Lexaria Bioscience Lagged Returns
When evaluating Lexaria Bioscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lexaria Bioscience stock have on its future price. Lexaria Bioscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lexaria Bioscience autocorrelation shows the relationship between Lexaria Bioscience stock current value and its past values and can show if there is a momentum factor associated with investing in Lexaria Bioscience Corp.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.